Yih‐Jyh Lin

Therapeutics targeting CD90-integrin-AMPK-CD133 signal axis in liver cancer

Wei-Ching Chen, Yung-Sheng Chang, Hui‐Ping Hsu et al. · Oncotarget · 2015 · 48 citations · Full text

Medicine, Medicinal Chemistry, Oncology +14

Impact of Immune Checkpoint Inhibitors with or without a Combination of Tyrosine Kinase Inhibitors on Organ-Specific Efficacy and Macrovascular Invasion in Advanced Hepatocellular Carcinoma

Hsin‐Yu Kuo, Nai‐Jung Chiang, Chiao‐Hsiung Chuang et al. · Oncology Research and Treatment · 2020 · 32 citations · Full text

Medicine, Oncology, Pharmacology +17

Resistance of ground glass hepatocytes to oral antivirals in chronic hepatitis B patients and implication for the development of hepatocellular carcinoma

Hung‐Wen Tsai, Yih‐Jyh Lin, Han‐Chieh Wu et al. · Oncotarget · 2016 · 29 citations · Full text

Medicine, Infectious Diseases, Pathobiology +17

The immune microenvironment features and response to immunotherapy in EBV-associated lymphoepithelioma-like cholangiocarcinoma

Nai‐Jung Chiang, Ya‐Chin Hou, Kien Thiam Tan et al. · Hepatology International · 2022 · 27 citations

Life Sciences, Immunology, Oncology +14

Real-world outcome of immune checkpoint inhibitors for advanced hepatocellular carcinoma with macrovascular tumor thrombosis

Hong‐Ming Tsai, Meng‐Zhi Han, Yih‐Jyh Lin et al. · Cancer Immunology Immunotherapy · 2021 · 25 citations · Full text

Medicine, Oncology, Pharmacology +17